Table 1.
Data of parturients
| Group D (n=36) | Group S (n=34) | P-value | |
|---|---|---|---|
|
| |||
| Age (years) | 27.3±3.6 | 26.7±3.1 | 0.460 |
| Weight (kg) | 70.8±4.7 | 69.5±5.4 | 0.289 |
| Height (cm) | 159.3±2.9 | 160.4±3.2 | 0.225 |
| Gestational age (weeks) | 39.8±1.2 | 40.1±1.3 | 0.323 |
| Onset of analgesia (minutes) | 14.4±3.4 | 13.9±2.6 | 0.542 |
| Duration of first stage (minutes) | 378.5±52.6 | 406.5±58.2 | 0.042* |
| Duration of second stage (minutes) | 38.6±5.4 | 40.3±6.7 | 0.251 |
| Blood loss (mL) | 192.7±13.8 | 198.3±14.5 | 0.108 |
| Mode of delivery (vaginal/cesarean) | 36/4 | 34/6 | 0.653 |
| 1-minute Apgar score | 8.7±0.7 | 8.9±0.6 | 0.181 |
| 5-minute Apgar score | 9.6±0.5 | 9.7±0.7 | 0.496 |
| Umbilical artery pH | 7.22±0.06 | 7.23±0.07 | 0.504 |
| Umbilical artery PaO2 (mmHg) | 28.8±2.5 | 29.7±3.3 | 0.488 |
| Ramsay Sedation Scale | 2.8±0.6 | 2.4±0.5 | 0.002* |
| Total analgesics (mL) | 71.5±12.2 | 78.1±10.5 | 0.021* |
Notes:
*
P<0.05 compared with group S. Data presented as mean ± SD or numbers. Group D received 0.5 µg/mL dexmedetomidine with 0.1% ropivacaine for epidural labor analgesia, and group S (control group) received 0.5 µg/mL sufentanil with 0.1% ropivacaine for labor analgesia.